Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Focal Epilepsy Clinical Trials

Reviewed by TrialFinderData Editorial Team · Updated

5 recruiting trials for Focal Epilepsy. Eligibility criteria explained in plain English.

TrialFinderData lists 5 Focal Epilepsy clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.

Across the trials that carry a phase, Phase 4 is the largest group at 50% (1 studies); the largest phase groups are Phase 4: 1, Phase 2 / Phase 3: 1.

Research is led by University of California, Davis (2), First Affiliated Hospital of Wenzhou Medical University (1), Biohaven Therapeutics Ltd. (1), among the most active sponsors registered for these trials.

The most frequently studied intervention is Placebo (drug, 2 trials), followed by BHV-7000, Virtual Tour Recognition Memory Task.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
5
Total Trials
5
Recruiting Now
0
Phase 3 Trials
4
Sponsors

Track Focal Epilepsy trials

Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT07580183

Spatial Scene Recognition Memory in Epilepsy Surgery

This study investigates the anatomical and physiological basis of spatial scene recognition memory in patients with temporal lobe epilepsy and temporal lobe lesions. Standard...

Sponsor: University of California, DavisEnrolling: 6202 locations
RECRUITINGPhase 4NCT07193277

Butylphthalide for Cognitive Impairment in Elderly Patients With Focal Epilepsy

This is a multicenter, randomized, double-blind, placebo-controlled trial evaluating the safety and efficacy of butylphthalide soft capsules for treating cognitive impairment in...

Sponsor: First Affiliated Hospital of Wenzhou Medical UniversityEnrolling: 2201 location
RECRUITINGPhase 2 / Phase 3NCT06309966

Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

The purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.

Sponsor: Biohaven Therapeutics Ltd.Enrolling: 39020 locations
RECRUITINGNCT04653012

Multi-level Approach of Brain Activity Using Intracranial Electrodes in Epileptic Patients

The main goal of this project is to study the mechanisms of epileptic activities using intracranial macro and micro electrodes in epileptic patients undergoing pre-surgical...

Sponsor: Institut National de la Santé Et de la Recherche Médicale, FranceEnrolling: 501 location
RECRUITINGNCT05794295

Sleep Architecture & Cognition in Focal Epilepsy

Focal Epilepsy (FE) patients and healthy controls will wear an actigraph at home for one week and a home sleep study device at home for one night. Participants will then undergo...

Sponsor: University of California, DavisEnrolling: 401 location

Frequently Asked Questions

There are currently 5 clinical trials for Focal Epilepsy, with 5 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Focal Epilepsy, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Focal Epilepsy, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.